Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (111-120 of 541) with videos related to

Pageof 55
Sort By:
Current Hypertension Reports|February 3, 2017
Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?Patricia Van der Niepen, Patrick Rossignol, Jean-Philippe Lengelé, et al.
European Journal of Heart Failure|April 17, 2018
Impact of the interruption of a large heart failure regional disease management programme on hospital admission rates: a population-based studyFrançois Alla, Nelly Agrinier, Marc Lavielle, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 29, 2019
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trialsSusan Stienen, Patrick Rossignol, António Barros, et al.
Journal of Hypertension|September 1, 2017
Individualizing treatment choices in the systolic blood pressure intervention trialJoão Pedro Ferreira, John Gregson, Kévin Duarte, et al.
Nephrologie & Therapeutique|July 5, 2022
[Current status of persistent chronic hyperkalaemia in France: An expert consensus based on a Delphi approach]Patrick Rossignol, Bruno Moulin, Jean-Michel Halimi, et al.
Trials|June 4, 2013
Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trialPatrick Rossignol, Marc Dorval, Renaud Fay, et al.
American Journal of Hypertension|December 12, 2017
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection FractionPatrick Rossignol, Brian Lee Claggett, Jiankang Liu, et al.
Journal of Hypertension|September 28, 2011
Influence of the recommendations on the implementation of home blood pressure measurement by French general practitioners: a 2004-2009 longitudinal surveyJean-Marc Boivin, Tzu-Jen Tsou-Gaillet, Renaud Fay, et al.
European Heart Journal|March 3, 2020
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trialMichael Böhm, João Pedro Ferreira, Felix Mahfoud, et al.
BMC Medicine|September 20, 2018
Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendationsAdrian Covic, Simonetta Genovesi, Patrick Rossignol, et al.
Pageof 55

Showing results (111-120 of 541) with videos related to

Sort By:
Pageof 55
Current Hypertension Reports|February 3, 2017
Renal Artery Stenosis in Patients with Resistant Hypertension: Stent It or Not?Patricia Van der Niepen, Patrick Rossignol, Jean-Philippe Lengelé, et al.
European Journal of Heart Failure|April 17, 2018
Impact of the interruption of a large heart failure regional disease management programme on hospital admission rates: a population-based studyFrançois Alla, Nelly Agrinier, Marc Lavielle, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 29, 2019
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trialsSusan Stienen, Patrick Rossignol, António Barros, et al.
Journal of Hypertension|September 1, 2017
Individualizing treatment choices in the systolic blood pressure intervention trialJoão Pedro Ferreira, John Gregson, Kévin Duarte, et al.
Nephrologie & Therapeutique|July 5, 2022
[Current status of persistent chronic hyperkalaemia in France: An expert consensus based on a Delphi approach]Patrick Rossignol, Bruno Moulin, Jean-Michel Halimi, et al.
Trials|June 4, 2013
Rationale and design of the HepZero study: a prospective, multicenter, international, open, randomized, controlled clinical study with parallel groups comparing heparin-free dialysis with heparin-coated dialysis membrane (Evodial) versus standard care: study protocol for a randomized controlled trialPatrick Rossignol, Marc Dorval, Renaud Fay, et al.
American Journal of Hypertension|December 12, 2017
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection FractionPatrick Rossignol, Brian Lee Claggett, Jiankang Liu, et al.
Journal of Hypertension|September 28, 2011
Influence of the recommendations on the implementation of home blood pressure measurement by French general practitioners: a 2004-2009 longitudinal surveyJean-Marc Boivin, Tzu-Jen Tsou-Gaillet, Renaud Fay, et al.
European Heart Journal|March 3, 2020
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trialMichael Böhm, João Pedro Ferreira, Felix Mahfoud, et al.
BMC Medicine|September 20, 2018
Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendationsAdrian Covic, Simonetta Genovesi, Patrick Rossignol, et al.
Pageof 55